← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Targeted Oncology (ISSN 1776-260X, 1776-2596) is a journal published by Springer Nature in Switzerland. It covers Biochemistry, Genetics and Molecular Biology, Medicine and Oncology. It is indexed in Scopus, Web of Science, PubMed and HEC. Recorded metrics: impact factor 5.1, Scopus Q1, Web of Science Q1, CiteScore 6.9 and HEC W-Category. Article processing charge: USD 5,190.

Journal title

Targeted Oncology

About the journal
—
ISSN
1776-260X, 1776-2596
Publisher
Springer Nature
Country
Switzerland
Subject area
BiochemistryGenetics and Molecular BiologyMedicineOncologyPharmacology (medical)Cancer Research
SJR
1.435
Indexed
ScopusWeb of SciencePubMedHEC
Open access
No
APC (USD)
5190
SCImago Ranking
2631
HEC
W-Category
Journal Website
www.springer.com/journal/11523 ↗
Registered In
2006
Instructions for Authors URL
—
Average Time To Publication After Submission (In Weeks)
—
APC Information URL
—
Impact Factor
5.1
Waiver policy
—
WoS Status
Science Citation Index Expanded (SCIE)
Scopus URL
www.scopus.com/sourceid/4700152489 ↗
Has any other fees
—
Scopus Cite Score
6.9
Aims and Scope
—
Scopus Quartile
Q1
WoS Quartile
Q1

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Targeted Oncology

Is Targeted Oncology HEC recognised?

Yes. The catalogue records Targeted Oncology in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Targeted Oncology indexed in Scopus?

Yes. Targeted Oncology is listed as Scopus-indexed, in quartile Q1, with a CiteScore of 6.9. Check its current status on the Scopus Sources page.

Is Targeted Oncology in Web of Science?

Yes. Targeted Oncology is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q1. Confirm on Clarivate's Master Journal List.

What is the impact factor of Targeted Oncology?

The recorded journal impact factor of Targeted Oncology is 5.1. Clarivate updates impact factors every year in Journal Citation Reports.

Is Targeted Oncology open access, and what does it charge?

Targeted Oncology is not recorded as fully open access and its APC is USD 5,190. Fees change, so check the journal's website before you submit.

Who publishes Targeted Oncology?

Targeted Oncology is published by Springer Nature in Switzerland, under ISSN 1776-260X and 1776-2596.

Research profile

Main research topics: Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, HER2/EGFR in Cancer Research, Lung Cancer Diagnosis and Treatment, Renal cell carcinoma treatment.

Source: OpenAlex (CC0), retrieved 20 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal